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BACKGROUND: Current diabetes management guide-
lines offer blueprints for providers, yet type 2 diabetes
control is often poor in disadvantaged populations. The
group visit is a new treatment modality originating in
managed care for efficient service delivery to patients
with chronic health problems. Group visits offer prom-
ise for delivering care to diabetic patients, as visits are
lengthier and can be more frequent, more organized,
and more educational.
OBJECTIVE: To evaluate the effect of group visits on
clinical outcomes, concordance with 10 American Diabe-
tes Association (ADA) guidelines [American Diabetes
Association,DiabetesCare,28:S4–36,2004]and3United
States Preventive Services Task Force (USPSTF) cancer
screens [U.S. Preventive Services Task Force, http://
www.ahrq.gov/clinic/uspstf/resource.htm, 2003].
RESEARCH DESIGN AND METHODS: A 12-month
randomized controlled trial of 186 diabetic patients
comparing care in group visits with care in the tradi-
tional patient–physician dyad. Clinical outcomes
(HbA1c, blood pressure [BP], lipid profiles) were
assessed at 6 and 12 months and quality of care
measures (adherence to 10 ADA guidelines and 3
USPSTF cancer screens) at 12 months.
RESULTS: At both measurement points, HbA1c, BP,
and lipid levels did not differ significantly for patients
attending group visits versus those in usual care. At
12 months, however, patients receiving care in group
visits exhibited greater concordance with ADA process-
of-care indicators (p < .0001) and higher screening rates
for cancers of the breast (80 vs. 68%, p = .006) and cervix
(80 vs 68%, p = .019).
CONCLUSIONS: Group visits can improve the quality of
care for diabetic patients, but modifications to the
content and style of group visits may be necessary to
achieve improved clinical outcomes.
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BACKGROUND
Over 18 million people in the United States have diabetes
mellitus (DM),
1 costing an estimated $132 billion in 2002.
2
Clinical practice guidelines, with measurable process-of-care
indicators (e.g., periodic monitoring of HbA1c and LDL levels)
and preventive services (e.g., foot examinations, vaccinations,
and cancer screens) facilitate management of patients with
type 2 DM. The typical 10 minute primary care visit provides
little time to address the up to 11 recommendations for type 2
diabetes, much less the 24.5 recommendations for the 15.4
risk factors with which the average patient presents.
3 The
group visit model developed in managed care to improve
efficiency and throughput of patients may provide an efficient
way to improve process-of-care delivery.
4 A recent article
suggested group visits as a strategy to address adherence to
guidelines.
5
Group visit literature remains relatively sparse, with only 5
articles reporting on randomized controlled trials.
4–8 Two
studies have shown group visits to be less costly and have
equal or better quality
4,5; 1 study demonstrated 4 years of
improved control in type 2 diabetic patients.
6 Studies in
disadvantaged patient populations are limited with the only
reported study by our own group.
5 This 6-month pilot study
showed a trend towards improved clinical outcomes and better
adherence to ADA process-of-care indicators in group visit
patients compared to regular care. The study was limited due
to only 1 physician leading group visits and the study duration
being too short to impact clinical outcomes. Thus, we designed
the current study with more patients, multiple providers, and
longer duration (12 months) to more definitively evaluate the
effectiveness of group visits in terms of quality of care and
clinical outcomes in disadvantaged patients with type 2
diabetes.
RESEARCH DESIGN AND METHODS
Study Population
This study was conducted at the Adult Primary Care Center
(APCC), Medical University of South Carolina (MUSC), serving
approximately 6,000 predominantly minority, inadequately
insured patients in Charleston, SC. Ten academic internal
medicine faculty physicians see patients and supervise resi-
dents, nurse practitioners, physician assistants, and students.
Eligible patients aged >18 years with poorly controlled diabetes
mellitus (HbA1c>8.0%) were identified through a query of the
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620APCC electronic medical record. All subjects signed written
informed consent documents approved by the MUSC Institu-
tional Review Board. Exclusion criteria included: primary
diagnosis of substance abuse or dependence; current preg-
nancy; dementia; and inability to hear, speak English, or
obtain transportation to the clinic. One of 5 consistent
interviewers invited identified patients to participate through
telephone or on-site solicitation using a standardized script.
Power, Sample Size, and Randomization
The primary outcome was adherence to 10 American Diabetes
Association (ADA) guidelines for diabetic care. The effect size of
interest was a 0.15 difference in the adherence rate, obtained
from the pilot study conducted by the group
5; 186 subjects
were required for a power of 80% at alpha of 0.05 to detect this
difference after adjusting for possible dropouts and crossovers.
Subjects meeting criteria for inclusion into the study were
randomized after informed consent and baseline data collec-
tion using randlst software (http://odin.mdacc.tmc.edu/
anonftp/) allowing for stratification and blocking. Subjects
were stratified by race and gender using a block size of 4.
Intervention Condition
Group visits, co-led by 1 of 6 primary care internal medicine
physicians and 1 of 3 registered nurses in the clinic, were
modeled after those of the Cooperative Health Care Clinics
(CHCC) developed by Beck and Scott.
4 After reviewing perti-
nent literature and the CHCC orientation manual, participat-
ing physicians and nurses received onsite training by a senior
internist who previously conducted group visit training. Addi-
tionally, the previous coordinator/trainer for CHCC providers
and staff conducted a 3-hour educational session for clinic
staff members.
Patients randomized to group visits were divided into 6
cohorts consisting of 14–17 patients each. The cohorts met
monthly for 1 year on a different floor in the same building as
the clinic. One-on-one visits were available for care needed
between scheduled group visits or for specific medical needs
not amenable to group visits (e.g., Papanicolaou (PAP) smears,
abdominal exams, EKGs). Group visits were scheduled for
2 hours: 10–15 minutes for “warm-up” and socialization, 30–
45 minutes for an interactive discussion of a health-related
topic such as foot care or health eating strategies, and
60 minutes for one-on-one consultations with the physician.
While vaccinations, foot exams, medication adjustments,
laboratory orders, and referrals for retinal examinations could
be done in the group visits, mammograms and PAP smears
were scheduled separately. Group visit content, though pa-
tient-guided, was physician-directed to cover educational
topics included in the core curriculum of Sadur et al.
7 such
as nutrition, exercise, foot care, medications, complications of
diabetes, and the emotional aspects of diabetes.
Control Condition
Control patients received care in the clinic as usual, seeing
faculty or resident physicians, physician assistants, nurse
practitioners, or medical or physician assistant students with
access to a dietician and diabetes educator. The volume of
patients at the APCC, the clinic structure, and scheduling of
patients does not provide for consistency in patients’ providers
at each visit, with patients needing to be seen off schedule
likely seeing providers other than their own.
Data Collection
Data were collected at baseline, 6 months, and 12 months.
Research assistants, blind to study assignment, scheduled
patients by mail and phone for data collection appointments
and assisted those who needed help. Data collected included
HbA1c levels, lipid profiles (total cholesterol, HDL, LDL,
triglycerides), and blood pressures. Blood samples and blood
pressures were collected by trained dedicated personnel
blinded to patient assignments. Three BP readings were
measured per subject while sitting upright after 5 minutes of
rest 2 minutes apart.
9 All blood samples were sent to the same
laboratory for processing. Patients received modest compen-
sation for transportation and time at each data collection
point. Neither group of patients received any compensation for
actual medical care though the visit deposit fee for group
patients was $15/visit as compared to $45/visit for control
patients. The cost of the 12 scheduled group visits (at $15/
visit) was identical cost-wise to the guideline recommended
quarterly visits for diabetic patients ($45/visit).
Upon study completion, medical records were blindly ab-
stracted for the 10 ADA process-of-care indicators [>2 yearly
HgA1cs,
10,11 at least yearly cholesterol levels, treatment for
LDL cholesterol levels >100 mg/dl, yearly ophthalmologic
referrals, influenza vaccinations, foot exams, and checks for
microalbuminuria, ACE-inhibitor or ARB use, daily aspirin
(81 mg) unless contraindicated, and at least 1 pneumococcal
vaccine] and 3 cancer screens recommended by the United
States Preventive Services Task Force (USPSTF) including he-
moccult cards for colon cancer screening in patients >50 years
old,
12mammogramsforbreastcancerinwomenage50–69years,
and PAP smears for cervical cancer screening at least every
3 years in women with previously normal PAP smears and
intact uteri (more frequently if previous abnormal cytology).
Statistical Methods
Data were analyzed using the intention-to-treat principle once
randomized and baseline parameters were recorded. The t test
for continuous outcomes and nonparametric Wilcoxon rank
sum test for ordinal outcomes were used to compare differ-
ences between group visit and control conditions. For process-
of-care indicators, all patients randomized were analyzed.
Clinical data (HbA1c, cholesterol, and blood pressure levels)
for patients whose loss to follow-up was independent of treat-
ment effect had their last observations carried forward in the
analysis. Patients who were lost to follow-up with no available
information had their missing observations replaced with the
worst observations in their respective treatment groups.
Statistical analysis was performed in 2 levels. The first level
was a cross-sectional analysis comparing group differences at
each data collection point. Depending on the type of outcome
(continuous or discrete), t test, Fisher’s exact test, or nonpara-
metric Wilcoxon rank sum test was used to compare baseline
characteristics between the 2 groups. Linear regression models
were used for 6- and 12-month data adjusting for baseline
covariates (such as the baseline clinical outcome measures,
age, gender, race, educational level, reading level, and insur-
621 Clancy et al.: Group Visits and Practice Guidelines JGIMance type). The second level was longitudinal modeling ana-
lyzing data from all 3 data collection points. Mixed-effects
models were used to fit the longitudinal data. Each model
adjusted for baseline covariates, the dependency among
repeated measures from the same subject, and the heteroge-
neity among different subjects. Initially, the mean number of
the 10 ADA process-of-care indicators met in both groups was
compared. These data were further dichotomized by classifying
whether there was compliance with at least 3 items, 4 items,
etc. The proportions of patients who met these criteria were
presented and tests for 2 proportions from binary outcomes
were performed to compare treatment differences. SAS 9.1 was
used for all computations.
Results. Over a 24-week period from September 2002 to
February 2003, 506 patients whose last HbA1c level was
>8.0% were contacted by phone or on-site, 186 of whom met
criteriaforinclusionintothestudy, agreedtoparticipate,signed
informed consent, and completed baseline assessments.
Reasons for not participating were inability to make the
baseline data collection appointment, and transportation
issues. Of enrolled patients, 96 subjects were assigned to
group visits and 90 to usual care. One patient in the control
group died from unknown causes, and 2 group visit patients
died during the study (1 from adenocarcinoma of unknown
primary and the other from severe electrolyte anomalies due to
recently diagnosed DiGeorge syndrome). Of the 27 patients
who withdrew (13 control and 14 intervention patients), all
but 1 indicated a reason. Missing data for those who withdrew
from the study but continued to receive care at the clinic and
had HbA1c levels unchanged or better than their last study
obtained data (2 in intervention and 5 in control) were replaced
by their last study observation in the analysis. Thus, we
conservatively analyzed data that were the same as or worse
than their new clinic data. For withdrawn patients about whom
no information for withdrawal was given (2 in intervention and
5incontrol),andforthepatientwhodiedbeforethestudybegan
but after collection of baseline data (1 intervention patient),
worst observations for their treatment group were carried
forward—again, a conservative approach to missing data.
Demographic variables were well balanced between patients
randomized to group visits or usual care at baseline (Table 1).
For all subjects in the study, the average age was 56.1 years,
72% were female, 82.8% African American, and 33% married
at the time of the study. The mean self-reported educational
level for these patients was 10 years with an average Rapid
Estimate of Adult Literacy (REALM) Tool health literacy level of
6th grade.
13 Most patients had Medicaid or Medicare; 28%
were uninsured; and 26% reported working. Clinical variables
were also well balanced at baseline (Table 1) with a mean
HgbA1c level at baseline of 9.3% for group patients and 8.9%
for control patients. The mean total cholesterol level for group
patients was 193.4 and 196.1 mg/dl for control patients.
Blood pressures, triglycerides, LDL, and HDL levels showed no
significant baseline differences between the 2 groups.
Unadjusted analysis (Table 2) comparing patients in group
visits to usual care showed group visit patients more likely to
have had each of the ADA processes of care indicators, with
use of ACEI/ARB and ASA, pneumovax, flu shot, foot exam-
ination, and ophthalmology referrals significantly better on an
individual level. During the 1-year study, group patients were
more likely to have had more of the 10 ADA process-of-care
indicators (Fig. 1). More group patients had 3 or more process
items met than control patients (p =.0312), a difference
remaining highly significant (with all p>.0001) with the cut
point moved from 3 to 7, 8, 9, or 10 items. For example, 64
intervention patients (68.4%) had at least 8 process-of-care
indicators performed compared to 24 control patients (29.3%)
(p >.0001); 41 intervention patients (64.1%) had at least 9
process-of-care indicators performed as compared to only 9
control patients (11%) (p>.0001); and 17 intervention patients
(17.7%) and no control patients had all 10 process-of-care
indicators performed (p>.0001). Combining all indicators, the
mean number of criteria met in intervention patients was 7.93±
0.18 vs. 6.13 ± 0.22 in control patients (unadjusted p>.0001).A
2-sample Wilcoxon rank sum test also resulted in p>.0001.
Significance persisted after controlling for selected covariates
including intensity of care assessed by the number of primary
care visits, and the number of comorbid risk factors. Women
participating in group visits were significantly more likely to
meet adherence to guidelines for PAP smears and screening
Table 1. Comparison of Sociodemographic Factors at Baseline
Variable Group Control P value
Number of patients 96 90
Gender (F)(%) 74 70 0.55
Race (B)(%) 82 84 0.69
Marital status
Single 30 32
Married 36 30
Divorced 11 10
Separated 13 8
Widowed 9 20 0.25
Current tobacco use 20 19 0.88
Employment
Full-time 13 21
Part-time 10 8
Retired 16 16
Unemployed 59 54 0.46
Age (years) 55 57 0.126
HbA1c (%)
Baseline 9.3±0.202 8.9±0.223 0.193
6 months
12 months 9.1±0.224 9.0±0.260 0.688
LDL (mg/dl)
Baseline 110.6±4.67 116.2±4.75 0.397
SBP mmHg
Baseline 137±2.33 132±2.97 0.261
DBP mmHg
Baseline 77.3±1.11 75.5±1.72 0.377
Table 2. Unadjusted Comparison of Individual Process-of-care
Variables
a
Variable (%) GV UC P value
ACEI/ARB 89 64 0.0004
Aspirin 81 48 <0.0001
Chol. meas. 79 61 0.0815
Chol. treated 76 59 0.1246
HbA1c 79 62 0.1193
Microalbumin 42 33 0.5119
Pneumovax 78 49 0.0004
Influenza vaccine 74 46 0.0008
Foot examination 65 28 <0.0001
Eye examination 75 53 0.0171
aAnalysis by chi square
622 Clancy et al.: Group Visits and Practice Guidelines JGIMmammograms; neither sex was more likely to meet adherence
guidelines for colon cancer screening.
Data analyzed from group visits only revealed significant
differences in ADA criteria met between the different physi-
cians conducting groups. The estimated intracluster correla-
tion coefficient (ICC) of the ADA criteria met is 0.25 (95% CI:
0.21, 0.29), indicating the ADA criteria met by subjects seen in
the same physician group (within cluster) were more similar
than the criteria met between subjects seen by different
physicians groups (between cluster).
At 12 months both intervention and control patients had
varying total cholesterol, triglyceride, LDL, and HDL levels,
though none were significant. After examining data from all
3 visits, longitudinal mixed-effects models were fitted for each
of the 5 clinical outcomes (HgbA1c. cholesterol, TG, HDL, and
LDL). All models were adjusted for number of ADA criteria met,
educational levels, health literacy levels, race, gender, insur-
ance types, and interactions between any 2 of these covariates.
Anyinteraction notfoundtobesignificantwasdropped, andthe
model was fitted again. No significant treatment effects were
found for any of these 5 clinical outcomes (p values range from
0.11 to 0.88). Repeat analysis using per protocol data gave
similar results.
DISCUSSION
This study reveals significant differences between group visit
(intervention) and control patients in adherence to ADA
standards of care and guidelines for PAP smears and screening
mammograms.
10,12 Perhaps the longer duration of group visits
provides more time to address guidelines than a typical
primary care encounter. Additionally, providers can deliver
consistent messages to multiple patients simultaneously in
group visits, rather than repeating them individually to
multiple patients. Monthly appointments provide more fre-
quent contact with the physician increasing opportunities to
systematically address guidelines. These findings support
those from previous studies revealing more frequent primary
care visits to be associated with an increased likelihood of
diabetic patients having >2 HbA1c levels performed annual-
ly.
11 Our study refutes results from previous studies suggest-
ing women attending more frequent general internal medicine
visits have a higher likelihood of receiving recommendations
for mammograms without improved patient adherence
14;
group visit women had higher rates of adherence to guidelines
for breast and cervical cancer screening.
Though group patients had more overall primary care visits,
due to the group visits being scheduled monthly, they averaged
1.0 individual primary care visits over the year compared with
3.8 for control patients. Physicians and patients accepted
group visits as physicians continued to schedule groups and
patients continued to attend groups after the study period.
Furthermore, the show rate for group visits was similar to that
for the clinic.
Discussion of individual patient issues in groups may have
contributed to other patients’ accepting process-of-care refer-
rals and tests, from diminished anxiety and a desire to show
other group members’ commitment to their own health care.
With open general discussions in group visits, patients poten-
tially educate each other about referrals and tests experienced;
perhaps hearing information from their peers resulted in
higher acceptance of suggestions from the physicians.
The direct effects of the education at each group visit are
difficult to assess from this study, but improvement in
concordance with process-of-care indicators in group patients
compared with control patients suggests significant effects.
Differences in the number of ADA criteria met by patients seen
in groups led by different physicians suggest physician
methodologies may have affected group teaching skills and
educational topics selected, or there were differences in group
dynamics affecting their approach to guideline adherence
Patients’ financial limitations likely led to significant differ-
ences in blood sugar, lipid, or blood pressure control, by
prohibiting purchase of prescribed medications, thus creating
a ceiling effect for benefits of improved guideline adherence.
Lack of standardization of group visit content may also have
contributed, as providers approached educational topics indi-
vidually. Perhaps a manualized, consistent curriculum would
improve clinical outcomes. The low health literacy level of most
of the study patients and the lack of physicians’ awareness of
their health literacy levels may have contributed to the lack of
clinical outcomes. As group visits were conducted under the
control of the providers, positive results (more process-of-care
indicators met) were also under the providers’control. Clinical
outcomes were under the patients’ control, depending on them
following lifestyle guidelines and adhering to medication regi-
mens. Incorporating motivational and behavioral strategies
emphasizing patients’ daily responsibilities and skill building
for healthy lifestyles compatible with diabetes may affect
improvements in clinical outcomes. Also, the study may have
lacked enough power to show a significant difference in the
outcome clinical variables because the sample size was
calculated to detect a difference in proportion of ADA processes
of care met by those in group visits compared to usual care.
Six different providers conducting group visits strengthens
in this study. These providers also had patients in the usual
care arm as part of the general pool of clinic patients; thus, it is
possible through contamination that providers may have
adopted some of the group visit strategies (e.g., group visit
educational content) for control patients. While unlikely, the
time constraints of a typical primary care visit may have
contributed to the failure to determine a difference in clinical
outcome variables. Provider randomization to prevent contam-
Figure 1. Process-of-care indicator adherence comparisons.
623 Clancy et al.: Group Visits and Practice Guidelines JGIMination is unrealistic as it is unlikely in any practice that a
provider would deliver care only in group visits.
CONCLUSION
This study of group visits in disadvantaged patients with type 2
diabetes reveals significant improvements in process-of-care
indicators for diabetes and sex/age appropriate cancer screen-
ing without differences in medical outcomes. Those who
conduct and study group visits may need to consider modifica-
tions to improve clinical outcomes while maintaining the gains
made in guideline concordance and efficiency of care delivery.
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